Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transductional targeting with recombinant adenovirus vectors.

Valerie Legrand1, Philippe Leissner, Arend Winter

  • 1TRANSGENE S.A., 11 rue de Molsheim, 67085 Strasbourg, France. vlegrand@carex.fr

Current Gene Therapy
|August 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxford Nanopore enhanced accuracy of long-read amplicons applied to microbial whole-genome sequencing.

Microbiology spectrum·2026
Same author

PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Liver cancer·2024
Same author

Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study.

BMC endocrine disorders·2023
Same author

Comparison of DNA extraction methods for 16S rRNA gene sequencing in the analysis of the human gut microbiome.

Scientific reports·2023
Same author

Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients.

Cancers·2022
Same author

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.

Cancer immunology research·2022
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
Same journal

Screening and Functional Study of Biomarkers Related to Cell-in-cell Structure in Stomach Adenocarcinoma.

Current gene therapy·2026
Same journal

HOXC4 Is Associated with the Prognosis and Immune Cell Infiltration in the Progression of Prostate Cancer.

Current gene therapy·2026
See all related articles

Replication-deficient adenoviruses offer broad gene delivery but can harm normal tissues. Strategies to restrict viral tropism enhance safety and efficiency for gene therapy, especially in cancer treatment.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Replication-deficient adenoviruses are promising gene delivery vectors for treating various diseases.
  • Their broad tissue tropism enables efficient gene expression in diverse cell types.
  • However, this broad tropism poses risks when delivering genes for harmful proteins to normal tissues.

Purpose of the Study:

  • To review strategies for selectively modifying the natural tropism of recombinant adenoviruses.
  • To discuss the advantages, limitations, and impact of these modified vectors on gene therapy.

Main Methods:

  • Review of existing literature on tropism modification strategies for adenoviral vectors.
  • Analysis of techniques used to restrict viral tropism.

Related Experiment Videos

Main Results:

  • Various strategies exist to selectively alter adenoviral tropism.
  • These modifications aim to enhance targeting specificity and reduce off-target effects.
  • The review discusses the implications of these modified vectors for gene therapy.

Conclusions:

  • Modifying adenoviral tropism is crucial for safer and more effective gene delivery.
  • Targeted tropism restriction is particularly important for cancer gene therapy.
  • Further research into these modified vectors will advance gene therapy applications.